/
DRTS
$14.50+$0.63 (+4.54%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.3B
90M shares
52-week range
$3.00 – $14.75
98% from low
Exchange
NASDAQ
CS
Change+$2.59
Alpha Tau Medical Ltd. Ordinary Shares
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
www.alphatau.com- Employees
- 121
- IPO / List date
- Mar 8, 2022
Held by traders on TradeandTell
No one on the platform currently holds DRTS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 40,457 | $286.0K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded DRTS yet.
